Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase the potential risk of treatment-induced mania in patients. Ketamine has also been applied to establish animal models of mania...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Rong-Jun, Gao, Tian-Hao, Wang, Yi-Yan, Tian, Yang, Wei, Jin-Xue, Zhao, Lian-Sheng, Ni, Pei-Yan, Ma, Xiao-Hong, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700503/
https://www.ncbi.nlm.nih.gov/pubmed/36257830
http://dx.doi.org/10.24272/j.issn.2095-8137.2022.278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700503/
https://www.ncbi.nlm.nih.gov/pubmed/36257830
http://dx.doi.org/10.24272/j.issn.2095-8137.2022.278

Ejemplares similares